Regulations.gov document
Acknowledgment Letter from FDA DMS to Xiromed, LLC (Xiromed) on behalf of Xiromed Pharma…
Other · FDA-2021-P-1108 · posted Oct 14, 2021
Key facts
| Document ID | FDA-2021-P-1108-0002 |
|---|---|
| Title | Acknowledgment Letter from FDA DMS to Xiromed, LLC (Xiromed) on behalf of Xiromed Pharma España S.L. |
| Document type | Other |
| Subtype | Acknowledgement Letter/Receipt |
| Agency | FDA |
| Docket | FDA-2021-P-1108 |
| Posted | Oct 14, 2021 |
| Comment period opens | Oct 14, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: